About this trial
Non-invasive ventilation (NIV) is a way to support breathing using a mask or helmet instead of a breathing tube, and it is proven to reduce the need for intubation, save lives, shorten hospital stays, and lower costs. While NIV has long been used in intensive care units, it is now increasingly applied in emergency rooms, hospital wards, and long-term care facilities. However, global data on how it is used outside ICUs-such as which patients receive it, how well it works, and what barriers exist-is lacking. The NIV-Safety Study is a worldwide survey of doctors, nurses, and respiratory therapists to understand current practices, outcomes, and challenges of NIV use beyond the ICU. The findings aim to guide safer, more effective, and standardized use of NIV across different healthcare settings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
physicians, nursing officers, and Respiratory therapists who treat patients with NIV
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
prevalence of non-invasive ventilation (NIV) use outside the ICU
To assess the prevalence of non-invasive ventilation (NIV) use outside the ICU
Secondary outcomes
Common conditions treated with NIV in non-ICU settings
the common respiratory conditions who are treated with NIV in non-ICU settings.
outcomes of using NIV in non-ICU settings
Outcome of NIV (success/failure) if used in non-ICU settings
Barriers and challenges faced while using NIV in non-ICU settings
Barriers and challenges faced by healthcare personals while using NIV in non-ICU settings
Other outcomes
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Dr. Ram Manohar Lohia Hospital
Lead sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Collaborator
Hamad Medical Corporation
Collaborator
Instituto Murciano de Investigación Biosanitaria (IMIB)
Collaborator